[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 17, 1993

What Is Age-Associated Memory Impairment?

JAMA. 1993;269(11):1356. doi:10.1001/jama.1993.03500110016005

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


A CONCERTED attack on age-associated memory impairment is planned by a newly formed consortium of five medical centers.

The institutions will pool efforts, determine protocols, and share data with the object of discovering how to treat and prevent memory loss in the aging brain. The consortium is being established with an $8.4 million contribution from the Charles A. Dana Foundation, New York, NY.

Eventually, the foundation could spend as much as $25 million on the project.

Catalyst Foundation  David Mahoney, foundation chair and chief executive officer, says that, "by bringing these institutions—each of which has unique talents and resources— together, the foundation becomes the catalyst." Speaking at a press conference in New York, he said that the five institutions forming what is being called the Dana Consortium on Memory Loss and Aging are Columbia University College of Physicians and Surgeons, New York; Mount Sinai School of Medicine of the City